DermTech Statistics
Total Valuation
DermTech has a market cap or net worth of 3,526. The enterprise value is 14.69 million.
| Market Cap | 3,526 |
| Enterprise Value | 14.69M |
Important Dates
The next estimated earnings date is Friday, August 1, 2025.
| Earnings Date | Aug 1, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
DermTech has 35.26 million shares outstanding.
| Current Share Class | 35.26M |
| Shares Outstanding | 35.26M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +1.11% |
| Owned by Insiders (%) | 1.85% |
| Owned by Institutions (%) | 0.01% |
| Float | 32.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| PB Ratio | 0.00 |
| P/TBV Ratio | 0.00 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.16 |
| EV / Sales | 0.94 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.20 |
Financial Position
The company has a current ratio of 3.53, with a Debt / Equity ratio of 1.34.
| Current Ratio | 3.53 |
| Quick Ratio | 3.31 |
| Debt / Equity | 1.34 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.74 |
| Interest Coverage | -17,300.40 |
Financial Efficiency
Return on equity (ROE) is -121.75% and return on invested capital (ROIC) is -42.16%.
| Return on Equity (ROE) | -121.75% |
| Return on Assets (ROA) | -38.60% |
| Return on Invested Capital (ROIC) | -42.16% |
| Return on Capital Employed (ROCE) | -95.63% |
| Revenue Per Employee | 75,671 |
| Profits Per Employee | -432,986 |
| Employee Count | 208 |
| Asset Turnover | 0.11 |
| Inventory Turnover | 11.92 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.89% in the last 52 weeks. The beta is 25.98, so DermTech's price volatility has been higher than the market average.
| Beta (5Y) | 25.98 |
| 52-Week Price Change | -99.89% |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 38.84 |
| Average Volume (20 Days) | 8,089 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 28.62 |
Income Statement
In the last 12 months, DermTech had revenue of 15.66 million and -89.63 million in losses. Loss per share was -2.67.
| Revenue | 15.66M |
| Gross Profit | 1.33M |
| Operating Income | -86.50M |
| Pretax Income | -89.63M |
| Net Income | -89.63M |
| EBITDA | -84.65M |
| EBIT | -86.50M |
| Loss Per Share | -2.67 |
Balance Sheet
The company has 38.98 million in cash and 53.67 million in debt, giving a net cash position of -14.69 million or -0.42 per share.
| Cash & Cash Equivalents | 38.98M |
| Total Debt | 53.67M |
| Net Cash | -14.69M |
| Net Cash Per Share | -0.42 |
| Equity (Book Value) | 39.99M |
| Book Value Per Share | 1.14 |
| Working Capital | 31.68M |
Cash Flow
In the last 12 months, operating cash flow was -72.07 million and capital expenditures -145,000, giving a free cash flow of -72.22 million.
| Operating Cash Flow | -72.07M |
| Capital Expenditures | -145,000 |
| Free Cash Flow | -72.22M |
| FCF Per Share | -2.05 |
Margins
| Gross Margin | 8.51% |
| Operating Margin | -552.23% |
| Pretax Margin | -572.19% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
DermTech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.45% |
| Shareholder Yield | n/a |
| Earnings Yield | -2,541,917.19% |
| FCF Yield | -2,048,071.47% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
DermTech has an Altman Z-Score of -7.66 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.66 |
| Piotroski F-Score | 3 |